Artificial Transcription Factors
FULL PAPER
other chemicals and reagents were obtained commercially and used with-
out further purification. Electrophoresis grade agarose, plasmid DNA
(pUC18), polyACHTUNGTRENNUNG(dA–dT)·polyACHTUTNGRENNUG(dA–dT) and polyACHNUTGERTG(NNUN dC–dG)·polyACHTNUGRTEN(NUGN dC–dG)
were purchased from Promega Corporation. Calf thymus DNA (CT
DNA) was purchased from Sigma (USA) Company and used as received.
tration and evaporation of the mixture yield yellow solid. Subsequently,
the Boc groups were removed with TFA (0.4 mL) in CH2Cl2 (2 mL). The
crude product was purified by a silica gel column with CHCl3/CH3OH/
NH3·H2O (66:33:1) as eluent to obtain the title compound (347.5 mg,
35%). 1H NMR (600 MHz, [D6]DMSO): d=1.85 (m, 2H), 2.73 (m, 8H),
2.79, 2.80 (s, 6H), 2.84 (m, 8H), 3.05–3.12 (br, 18H), 3.25 (q, 2H, J=6.0),
3.74 (s, 4H), 3.82–3.86 (br, 12H), 6.79 (s, 1H), 6.93 (s, 2H), 6.96–7.10 (br,
4H), 7.15–7.20 (br, 4H), 8.14 (s, 1H), 9.46–9.93 (br, 4H), 10.16 ppm (s,
1H); 13C NMR (100 MHz, [D6]DMSO): d=165.56, 162.24, 159.34, 159.11,
158.45, 136.84, 125.16, 123.18, 122.92, 122.25, 121.29, 119.16, 118.04,
115.98, 105.30, 105.08, 67.49, 55.62, 55.23, 47.41, 44.81, 42.69, 42.35, 42.22,
39.99, 39.86, 39.72, 39.59, 39.45, 39.31, 39.18, 36.44, 35.82, 25.01 ppm; MS
(ESI+): m/z: 1094 [M+HÀ7TFA]+; HRMS (ESI+): m/z: calcd for
Synthesis of bis-cyclen-Py4Dp: Detailed compound structures and synthe-
sis route of Bis-Cyclen-Py4Dp are given in the Supporting Information
(Scheme S1).
Compound 2: Compound 1 was dissolved in DMF (30 mL) containing
anhydrous K2CO3 (1.38 g, 10.0 mmol) with stirring at room temperature.
Then, BnBr (1.78 mL, 15 mmol) was dropwise to the solution above for
30 min. After 4 h, the reaction was quenched by cold water (100 mL) and
solution was extracted with CHCl3 (50 mLꢂ6). The combined organic
phases were washed with saturated aqueous NaCl and dried over
Na2SO4. Filtration and evaporation of the solvent yield compound 2
(2.34 g, 78%). MS (ESI+): m/z: 323 [M+Na]+.
C57H87N18O8F3: 604.3454; found: 604.3453 [M+2H]2+
.
ImPyImPy-g-Vc: The detailed structure and synthesis route of ImPyIm-
Py-g-Vc are given in the Supporting Information (Scheme S1). Treatment
of l-ascorbic acid with acetyl chloride in acetone afforded the 5,6-ketal
of l-ascorbic acid. Benzylation of the C-2’ and C-3’ hydroxy groups of
the lactone ring in compound 7 was accomplished by using K2CO3 and
benzyl bromide in DMF to provide compound 8. Deblocking of the 5,6-
O,O-protected derivative of l-ascorbic acid 8 with acetic acid in metha-
nol gave 2,3-O,O-dibenzyl-l-ascorbic acid (9). The flexible g-aminobuty-
ric acid linker was conjugated to compound 9 by BOP reagent and
DIEA to obtain compound 10. Then the polyamide backbone ImPyIm-
PyCOOH and compound 10 were conjugated by BOP reagent and
DIEA in DMF/dichloromethane. Finally, the hydrogenation reaction cat-
alyzed by Pd/C removed the benzyl group. The desired product was puri-
fied by silica gel column chromatography with CHCl3/CH3OH 60:40 as
eluent.1H NMR (600 MHz, [D4]CD3OD): d=7.46 (s, 2H), 7.39 (d, 1H),
7.28 (s, 2H), 7.04–7.08 (d, 1H), 6.85 (s, 1H), 4.75 (d, 1H), 4.26 (m, 1H),
4.25 (m, 1H), 4.24 (s, 1H), 4.23 (s, 6H), 4.08 (s, 3H), 3.97 (s, 3H), 2.49 (t,
2H), 1.94 (t, 2H), 1.55 ppm (t, 2H); 13C NMR (100 MHz, [D6]DMSO):
d=174.0, 173.1, 162.6, 160.7, 157.9, 157.7, 156.3, 154.4, 154.2, 146.0, 134.7,
131.4, 131.2, 130.8, 130.5, 126.0, 125.9, 123.5, 120.3, 120.1, 118.5, 77.3,
65.7, 65.6, 39.8, 37.3, 36.9, 34.4, 34.7, 31.0, 23.7 ppm; MS (ESIÀ): m/z:
734.5 [M]À; HRMS (ESI+): m/z: calcd for C32H36O11N10: 737.2643; found:
737.2638 [M+H]+.
Compound 3: Compound
2 (1.20 g) dissolved in anhydrous THF
(70 mL), which was dropwise to suspension THF (20 mL) containing
LiAlH4 (0.77 g, 20 mmol) for 30 min at 08C under an N2 atmosphere.
After 2 h, CH3OH (5 mL), H2O (5 mL) and NaOH (10 mL, 10%) were
added in the solution above, respectively, and the mixture was filtrated
with celatom. Evaporation of solution gave compound 3 (0.97 g, 99%) as
yellow solid. MS (ESI+): m/z: 251 [M+Li]+.
Compound 4: Compound 3 (0.73 g, 3.0 mmol) was dissolved in anhydrous
CH2Cl2. PBr3 (0.66 mL, 6.9 mmol) was added in the solution with stirring
3 h at 08C under an N2 atmosphere. After warming to room temperature,
the mixture was poured in cold water (70 mL), and its pH was adjusted
to pH 7.0–7.2 using saturated aqueous NaHCO3. The solution was ex-
tracted with Et2O (50 mLꢂ5). The combined organic phases were dried
over Na2SO4. Filtration and evaporation of the solvent yield compound 4
(0.68 g, 61%). MS (ESIÀ): m/z: 372 [M]À.
Compound 5: Under an N2 atmosphere, 3Boc-Cyclen (1.39 g, 2.95 mmol)
was dissolved in CH3CN (70 mL) and compound 4 (0.55 g, 1.48 mmol)
and anhydrous Na2CO3 (0.38 g, 3.57 mmol) was added in the solution.
The remaining reaction was refluxed at 858C for 20 h. Filtration and
evaporation of the solvent yield yellow solid. Crude product was purified
by a silica gel column with ethyl acetate/petroleum ether (50:50) as
Circular dichroism measurements: All experiments were performed
under a continuous flow of nitrogen using a Jasco-720 spectropolarimeter.
A path length cell of 1 cm was used and all experiments were performed
at room temperature. A 0.5 mm solution of cyclen, Py4Dp and cyclen-
Py4Dp was titrated into the DNA solutions (at pH 8.0, 10 mm Tris-HCl
buffer with 10 mm NaCl). The standard scan parameters for all experi-
ments were as follows: The wavelengths were scanned from 400 to
220 nm. The sensitivity was set at 100 mdeg and the scan speed was set at
200 nm per minute. Three scans were accumulated and averaged by the
computer.
eluent. 1H NMR (600 MHz, CDCl3): d=1.40, 1.44 (br, 54H, OC
ACTHNUGTRNEUGN(CH3)3),
2.60 (m, 8H, CH2NCH2), 3.2–3.29 (m, 16H, NCH2CH2), 3.56 (m, 8H,
NCH2CH2), 3.68 (s, 4H, NCH2Ar), 4.97 (s, 2H, OCH2Ar), 6.61 (s, 1H,
OArH4), 6.75 (s, 2H, OArH2, OArH6), 7.25–7.28 (br, 1H, ArH4), 7.33–
7.36 ppm (br, 4H, ArH2, ArH3, ArH5, ArH6); 13C NMR (100 MHz,
CDCl3): d=155.73, 137.45, 128.53, 127.93, 127.43, 115.94, 79.41, 69.92,
56.04, 55.47, 54.15, 49.86, 47.95, 28.47 ppm; MS (ESI+): m/z: 1176
[M+Na]+.
Compound 6: Compound
5 (230.8 mg, 0.2 mmol) and Pd/C (5%)
(22.7 mg) were added to anhydrous CH3CH2OH. The solution was stirred
at 1 atm under an H2 atmosphere. After 3 h, filtration and evaporation of
the residue gave brown solid (161.7 mg, 76%). 1H NMR (600 MHz,
Plasmid DNA cleavage: Electrophoresis experiments were performed
with plasmid DNA (pUC18). In a typical experiment, supercoiled pUC18
DNA (5 mL, 0.08 mgmLÀ1) in Tris-HCl buffer (40 mm) was treated with
different concentration ligands (dissolved in dimethyl sulfoxide, Vc
system in water) at different pH value, followed by dilution with the Tris-
HCl buffer to a total volume of 80 mL. The samples were then incubated
at different temperature and time intervals, and loaded on a 1% agarose
gel containing ethidium bromide (1.0 mgmLÀ1). Electrophoresis was car-
ried out at 85 V for 1 h in TAE buffer. Bands were visualized by UV
light and photographed followed by the estimation of the intensity of the
DNA bands using a Gel Documentation System.
CDCl3): d=1.24–1.71 (br, 54H, OCACHTNUTRGNEUNG(CH3)3), 2.11–2.61 (m, 8H,
CH2NCH2), 3.35–3.70 (m, 24H, NCH2CH2), 4.11–4.17 (s, 4H, NCH2Ar),
6.85 (s, 1H, ArH4), 7.38, 7.73 ppm (s, 2H, ArH2, ArH6); MS (ESI+): m/z:
1064 [M+H]+.
The above-mentioned product (424.8 mg, 0.40 mmol), anhydrous K2CO3
(55.4 mg, 0.40 mmol) and BrCH2CH2COOEt (134 mL, 1.20 mmol) were
added to acetone (25 mL). The solution was extracted with ethyl acetate
(40 mLꢂ4) and dried over Na2SO4 after refluxed for 10 h. Filtration and
evaporation of the solution yield yellow solid. Subsequently, it was hydro-
lyzed to obtain the corresponding acid compound 6 (391.6 mg, 95%).
Fluorescence quenching assay: Fluorescence spectra were recorded on
Hitachi model F-4500 spectrofluorimeter, with excitation and emission
band bass: 10 nm (lex =520, lem =620 nm). 0.5 mm solution of Py4Dp, bis-
cyclen and bis-cyclen-Py4Dp were titrated into the DNA-EB solution at
pH 8.0 10 mm Tris-HCl buffer with 10 mm NaCl. Apparent binding con-
stants (Kapp) of the ligands with CT DNA were estimated and compared
by measuring the loss of EtBr fluorescence as a function of added ligand.
The Kapp values were calculated from: KEtBr·ACTHNUGRTENNU[G EtBr]=Kapp·ACHTGNUTREN[NUNG ligand], where
[EtBr] and KEtBr are the concentrations and binding constants of EtBr,
respectively, and [ligand] is the concentration of ligand at 50% of maxi-
1H NMR (300 MHz, CDCl3): d=1.23–1.47 (br, 54H, OC
ACTHUNGTRNEUNG(CH3)3), 2.86 (br,
8H, CH2NCH2), 3.40–3.89 (m, 28H, NCH2CH2, NCH2Ar), 4.62 (br, 2H,
ArOCH2), 6.96 ppm (br, 3H, ArH2, ArH4, ArH6); MS (ESI+): m/z: 1122
[M+H]+.
Bis-cyclen-Py4Dp: Compound 6 (657.2 mg, 0.59 mmol) was converted
into activated esters with HOBt (135.1 mg, 1 mmol) and DCC (206.5 mg,
1 mmol) in CH2Cl2 (20 mL). NH2Py4Dp was added to the stirred solution
in room temperature and the reaction mixture was stirred overnight. Fil-
Chem. Eur. J. 2010, 16, 12935 – 12940
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
12939